Philips has secured FDA 510(k) clearance for SmartSpeed Precise, a dual AI software aimed at accelerating MR scans and improving image quality.

The technology was introduced at ECR 2025, and it is now approved for clinical use across the company's entire 1.5T and 3.0T MR portfolio, including systems already in use.

SmartSpeed Precise combines Philips’ Compressed SENSE acceleration engine with two AI components — one for denoising and another for sharpening — to enhance imaging speed and clarity. According to Philips, the software can deliver scans up to three times faster and generate images up to 80% sharper compared to earlier SENSE and Compressed SENSE protocols. These capabilities are available through a single-click workflow intended to ease adoption across teams with varying levels of MR expertise.
“This FDA clearance is a powerful validation of Philips’ leadership in AI-powered MR innovation,” said Ioannis Panagiotelis, business leader MR at Philips. “By integrating dual AI with our proven Compressed SENSE engine, we are enabling faster, sharper, and smarter MR scans.”

The software is designed to help address growing operational pressures in radiology, including rising scan volumes, staffing shortages, and burnout. With its simplified workflow, Philips aims to increase throughput and reduce patient wait times without requiring new hardware investments.

“SmartSpeed Precise helps us do what was previously thought impossible: deliver sharper, faster MR with less effort,” said Dr. Julian Luetkens, professor of radiology at University Hospital Bonn. He cited up to a 50% reduction in breast MR scan time with improved image quality.

SmartSpeed Precise is not yet CE marked and is not available for sale in Europe.

Artificial Intelligence Homepage